Malign cystic glucagonoma presented with diabetic ketoacidosis: Case report with an update

Endocrine-Related Cancer

Volumn 12, Issue 2, 2005, Pages 449-454

  Fenkci, S M ^a   Yaylali, G Fidan ^a   Sermez, Y ^a   Akdam, H ^a   Sabir, N ^a   Kirac S ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHROMOGRANIN; ESSENTIAL FATTY ACID; HEPARIN; INSULIN; OCTREOTIDE; PENTETREOTIDE IN 111; ZINC;

ADULT; ARTICLE; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DIABETIC KETOACIDOSIS; ERYTHEMA; FEMALE; GLUCAGONOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG EMBOLISM; MALIGNANT NEOPLASTIC DISEASE; NECROLYTIC MIGRATORY ERYTHEMA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS RESECTION; SCINTIGRAPHY; SKIN MANIFESTATION; SPLENECTOMY; TREATMENT OUTCOME;

ADULT; DIABETIC KETOACIDOSIS; ERYTHEMA; FEMALE; GLUCAGONOMA; HUMANS; LIVER NEOPLASMS; PANCREATIC NEOPLASMS;

EID: 21244444990     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.00957     Document Type: Article

References (8)

1. Alexander EK, Robinson M, Staniec M & Dluhy RG 2002 Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome. Clinical Endocrinology 57 827-831.
2. Anthony LB, Sharp SC & May ME 1995 Case report: diabetic ketoacidosis in a patient with glucagonoma. American Journal of Medical Science 309 326-327.
3. El Rassi Z, Partensky C, Valette PJ, Berger F & Chayvialle JA 1998 Necrolytic migratory erythema, first symptom of a malignant glucagonoma: treatment by long-acting somatostatin and surgical resection. Report of three cases. European Journal of Surgical Oncology 24 562-567.
4. Krausz EP, Kwekkeboom DJ, Bakker WH, et al. 1998 Somatostatin receptor scintigraphy in the management of gastroenteropancreatic tumors. American Journal of Gastroenterology 93 66-70.
5. Mallinson CN, Blomm SR, Warin AP, et al. 1974 A glucagonoma syndrome. Lancet 2 1-5.
6. Prinz RA, Badrinath K, Banerji M, Sparagana M, Dorsch TR & Lawrence AM 1981 Operative and chemotherapeutic management of malignant glucagon-producing tumors. Surgery 90 713-719.
7. Soga J & Yakuwa Y 1998 Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases. Journal of Hepatobiliary Pancreatic Surgery 5 312-319.
8. Wermers RA, Fatourechi V, Wynne AG, Kvols LK & Lloyd RV 1996 The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine 75 53-63.